Article
The impact of genetic variations in FPGS , MTHFR , and ATIC on methotrexate response among pediatric patients with acute lymphoblastic leukemia.
Pharmacogenetics and genomics - 1 Jun 2025
Wang Shu-Mei, Zhao Dan-Qi, Kong Xiao-Yan, Li Miao
Abstract excerpt
OBJECTIVES: Genetic polymorphisms in FPGS , MTHFR , and ATIC have emerged as important modulators of methotrexate (MTX) metabolism and toxicity. We investigated the distribution of FPGS rs10106, MTHFR rs1801131, and ATIC rs2372536 polymorphisms in children with acute lymphoblastic leukemia (ALL) and assessed their influence on MTX concentrations, toxicity profiles, and clinical outcomes. METHODS: Genotyping of...
Read the complete abstract on PubMed